nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—ABCC6—Dactinomycin—ocular cancer	0.374	0.442	CbGbCtD
Daunorubicin—XDH—Carboplatin—ocular cancer	0.157	0.186	CbGbCtD
Daunorubicin—ABCC1—Dactinomycin—ocular cancer	0.11	0.13	CbGbCtD
Daunorubicin—ABCG2—Dactinomycin—ocular cancer	0.0737	0.0872	CbGbCtD
Daunorubicin—ABCC2—Carboplatin—ocular cancer	0.0548	0.0648	CbGbCtD
Daunorubicin—ABCG2—Carboplatin—ocular cancer	0.0496	0.0586	CbGbCtD
Daunorubicin—ABCB1—Dactinomycin—ocular cancer	0.0266	0.0314	CbGbCtD
Daunorubicin—Radiation recall reaction (dermatologic)—Dactinomycin—ocular cancer	0.00529	0.151	CcSEcCtD
Daunorubicin—Recall phenomenon—Dactinomycin—ocular cancer	0.00501	0.143	CcSEcCtD
Daunorubicin—Extravasation—Carboplatin—ocular cancer	0.00268	0.0764	CcSEcCtD
Daunorubicin—Myelosuppression—Dactinomycin—ocular cancer	0.00185	0.0528	CcSEcCtD
Daunorubicin—Febrile neutropenia—Dactinomycin—ocular cancer	0.00144	0.0412	CcSEcCtD
Daunorubicin—Folliculitis—Dactinomycin—ocular cancer	0.00138	0.0394	CcSEcCtD
Daunorubicin—Hepatomegaly—Dactinomycin—ocular cancer	0.00123	0.035	CcSEcCtD
Daunorubicin—Necrosis—Dactinomycin—ocular cancer	0.00111	0.0315	CcSEcCtD
Daunorubicin—Extravasation—Dactinomycin—ocular cancer	0.000996	0.0284	CcSEcCtD
Daunorubicin—Ulcer—Dactinomycin—ocular cancer	0.000919	0.0262	CcSEcCtD
Daunorubicin—Infection—Carboplatin—ocular cancer	0.000829	0.0236	CcSEcCtD
Daunorubicin—Oesophagitis—Dactinomycin—ocular cancer	0.000794	0.0226	CcSEcCtD
Daunorubicin—Pain—Carboplatin—ocular cancer	0.000714	0.0203	CcSEcCtD
Daunorubicin—Body temperature increased—Carboplatin—ocular cancer	0.00066	0.0188	CcSEcCtD
Daunorubicin—Dysphagia—Dactinomycin—ocular cancer	0.000545	0.0155	CcSEcCtD
Daunorubicin—Pancytopenia—Dactinomycin—ocular cancer	0.000518	0.0148	CcSEcCtD
Daunorubicin—Neutropenia—Dactinomycin—ocular cancer	0.00051	0.0145	CcSEcCtD
Daunorubicin—Stomatitis—Dactinomycin—ocular cancer	0.000474	0.0135	CcSEcCtD
Daunorubicin—Flushing—Dactinomycin—ocular cancer	0.000405	0.0115	CcSEcCtD
Daunorubicin—Chills—Dactinomycin—ocular cancer	0.000392	0.0112	CcSEcCtD
Daunorubicin—Alopecia—Dactinomycin—ocular cancer	0.000386	0.011	CcSEcCtD
Daunorubicin—Erythema—Dactinomycin—ocular cancer	0.00038	0.0108	CcSEcCtD
Daunorubicin—Ill-defined disorder—Dactinomycin—ocular cancer	0.000352	0.01	CcSEcCtD
Daunorubicin—Anaemia—Dactinomycin—ocular cancer	0.000351	0.01	CcSEcCtD
Daunorubicin—Malaise—Dactinomycin—ocular cancer	0.000343	0.00976	CcSEcCtD
Daunorubicin—Leukopenia—Dactinomycin—ocular cancer	0.00034	0.00969	CcSEcCtD
Daunorubicin—Myalgia—Dactinomycin—ocular cancer	0.000323	0.00922	CcSEcCtD
Daunorubicin—Discomfort—Dactinomycin—ocular cancer	0.000319	0.00911	CcSEcCtD
Daunorubicin—Oedema—Dactinomycin—ocular cancer	0.00031	0.00883	CcSEcCtD
Daunorubicin—Infection—Dactinomycin—ocular cancer	0.000308	0.00878	CcSEcCtD
Daunorubicin—Thrombocytopenia—Dactinomycin—ocular cancer	0.000304	0.00865	CcSEcCtD
Daunorubicin—Anorexia—Dactinomycin—ocular cancer	0.000295	0.00842	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Dactinomycin—ocular cancer	0.000282	0.00805	CcSEcCtD
Daunorubicin—Decreased appetite—Dactinomycin—ocular cancer	0.000269	0.00768	CcSEcCtD
Daunorubicin—Fatigue—Dactinomycin—ocular cancer	0.000267	0.00762	CcSEcCtD
Daunorubicin—Pain—Dactinomycin—ocular cancer	0.000265	0.00755	CcSEcCtD
Daunorubicin—Feeling abnormal—Dactinomycin—ocular cancer	0.000255	0.00728	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Dactinomycin—ocular cancer	0.000253	0.00722	CcSEcCtD
Daunorubicin—Body temperature increased—Dactinomycin—ocular cancer	0.000245	0.00698	CcSEcCtD
Daunorubicin—Abdominal pain—Dactinomycin—ocular cancer	0.000245	0.00698	CcSEcCtD
Daunorubicin—Hypersensitivity—Dactinomycin—ocular cancer	0.000228	0.00651	CcSEcCtD
Daunorubicin—Asthenia—Dactinomycin—ocular cancer	0.000222	0.00634	CcSEcCtD
Daunorubicin—Diarrhoea—Dactinomycin—ocular cancer	0.000212	0.00604	CcSEcCtD
Daunorubicin—Vomiting—Dactinomycin—ocular cancer	0.000197	0.00562	CcSEcCtD
Daunorubicin—Rash—Dactinomycin—ocular cancer	0.000195	0.00557	CcSEcCtD
Daunorubicin—Nausea—Dactinomycin—ocular cancer	0.000184	0.00525	CcSEcCtD
Daunorubicin—YWHAG—Mitotic G2-G2/M phases—EP300—ocular cancer	0.000164	0.00138	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.000164	0.00137	CbGpPWpGaD
Daunorubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.000163	0.00137	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—RBL2—ocular cancer	0.000163	0.00136	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—MAML2—ocular cancer	0.000161	0.00135	CbGpPWpGaD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.00016	0.00134	CbGpPWpGaD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	0.00016	0.00134	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.00016	0.00134	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000158	0.00132	CbGpPWpGaD
Daunorubicin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	0.000158	0.00132	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—TGFB1—ocular cancer	0.000157	0.00132	CbGpPWpGaD
Daunorubicin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.000156	0.00131	CbGpPWpGaD
Daunorubicin—YWHAG—mTOR signaling pathway—AKT1—ocular cancer	0.000155	0.0013	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—CDK6—ocular cancer	0.000154	0.00129	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—CDK4—ocular cancer	0.000154	0.00129	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—RBBP4—ocular cancer	0.000154	0.00129	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—E2F3—ocular cancer	0.000154	0.00129	CbGpPWpGaD
Daunorubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.000151	0.00126	CbGpPWpGaD
Daunorubicin—TOP2A—Mitotic G1-G1/S phases—RB1—ocular cancer	0.000148	0.00124	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—CDC25A—ocular cancer	0.000146	0.00123	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—CCND3—ocular cancer	0.000145	0.00121	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—RB1—ocular cancer	0.000144	0.00121	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—TFDP1—ocular cancer	0.000143	0.0012	CbGpPWpGaD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.000139	0.00117	CbGpPWpGaD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.000139	0.00116	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—CDK6—ocular cancer	0.000138	0.00116	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.000138	0.00115	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000136	0.00114	CbGpPWpGaD
Daunorubicin—ABCG2—Fluoropyrimidine Activity—TP53—ocular cancer	0.000136	0.00114	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.000135	0.00113	CbGpPWpGaD
Daunorubicin—YWHAG—PDGFR-beta signaling pathway—MYC—ocular cancer	0.000134	0.00112	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.000133	0.00111	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—CCND2—ocular cancer	0.000133	0.00111	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—CCND3—ocular cancer	0.00013	0.00109	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—E2F1—ocular cancer	0.00013	0.00109	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—TP53—ocular cancer	0.000129	0.00108	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000129	0.00108	CbGpPWpGaD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—EP300—ocular cancer	0.000129	0.00108	CbGpPWpGaD
Daunorubicin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.000125	0.00105	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PSPH—ocular cancer	0.000125	0.00104	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—CDK4—ocular cancer	0.000124	0.00104	CbGpPWpGaD
Daunorubicin—CYP1A1—Tryptophan metabolism—MDM2—ocular cancer	0.000123	0.00103	CbGpPWpGaD
Daunorubicin—YWHAG—ErbB1 downstream signaling—HRAS—ocular cancer	0.000121	0.00101	CbGpPWpGaD
Daunorubicin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	0.000121	0.00101	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000119	0.000997	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—HDAC1—ocular cancer	0.000119	0.000995	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—CCND2—ocular cancer	0.000119	0.000995	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—HDAC1—ocular cancer	0.000117	0.000984	CbGpPWpGaD
Daunorubicin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	0.000115	0.000963	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	0.000112	0.00094	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	0.000112	0.00094	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	0.000112	0.000937	CbGpPWpGaD
Daunorubicin—TOP2A—Mitotic G1-G1/S phases—CCND1—ocular cancer	0.00011	0.000919	CbGpPWpGaD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.000109	0.000917	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000109	0.000915	CbGpPWpGaD
Daunorubicin—ABCG2—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.000109	0.000913	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—CDK6—ocular cancer	0.000108	0.000905	CbGpPWpGaD
Daunorubicin—YWHAG—ErbB1 downstream signaling—AKT1—ocular cancer	0.000107	0.000894	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—CDKN2B—ocular cancer	0.000106	0.000892	CbGpPWpGaD
Daunorubicin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	0.000106	0.000889	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—CDKN2B—ocular cancer	0.000105	0.000882	CbGpPWpGaD
Daunorubicin—YWHAG—PDGFR-beta signaling pathway—HRAS—ocular cancer	0.000105	0.00088	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.000104	0.000867	CbGpPWpGaD
Daunorubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.000103	0.00086	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—EP300—ocular cancer	9.85e-05	0.000825	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	9.85e-05	0.000825	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—E2F1—ocular cancer	9.77e-05	0.000819	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—CDK6—ocular cancer	9.66e-05	0.000809	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	9.54e-05	0.000799	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—CDK2—ocular cancer	9.43e-05	0.00079	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PSPH—ocular cancer	9.37e-05	0.000785	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—CCND2—ocular cancer	9.29e-05	0.000778	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—HDAC1—ocular cancer	9.29e-05	0.000778	CbGpPWpGaD
Daunorubicin—YWHAG—Apoptosis—TP53—ocular cancer	9.25e-05	0.000775	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—ocular cancer	9.19e-05	0.00077	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—EP300—ocular cancer	9.16e-05	0.000767	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PSPH—ocular cancer	9.06e-05	0.000759	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—CDK4—ocular cancer	8.91e-05	0.000746	CbGpPWpGaD
Daunorubicin—TOP2A—Mitotic G1-G1/S phases—MYC—ocular cancer	8.8e-05	0.000737	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	8.71e-05	0.00073	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—MYC—ocular cancer	8.59e-05	0.000719	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	8.56e-05	0.000717	CbGpPWpGaD
Daunorubicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	8.52e-05	0.000714	CbGpPWpGaD
Daunorubicin—NR5A1—Generic Transcription Pathway—MYC—ocular cancer	8.48e-05	0.00071	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—CDK2—ocular cancer	8.43e-05	0.000706	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—CDKN2B—ocular cancer	8.33e-05	0.000698	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	8.31e-05	0.000696	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—CCND2—ocular cancer	8.31e-05	0.000696	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—HDAC1—ocular cancer	8.31e-05	0.000696	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PSPH—ocular cancer	8.24e-05	0.00069	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PSPH—ocular cancer	8.16e-05	0.000683	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	8.04e-05	0.000674	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—CDK4—ocular cancer	7.97e-05	0.000667	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—TGFB1—ocular cancer	7.96e-05	0.000667	CbGpPWpGaD
Daunorubicin—CYP1A2—Tryptophan metabolism—MDM2—ocular cancer	7.84e-05	0.000656	CbGpPWpGaD
Daunorubicin—YWHAG—Apoptosis—AKT1—ocular cancer	7.81e-05	0.000654	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—RB1—ocular cancer	7.75e-05	0.000649	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	7.65e-05	0.000641	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—E2F1—ocular cancer	7.64e-05	0.00064	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—CDKN2B—ocular cancer	7.45e-05	0.000624	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—SAG—ocular cancer	7.41e-05	0.000621	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—EP300—ocular cancer	7.35e-05	0.000615	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	7.15e-05	0.000599	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	7.15e-05	0.000599	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—RB1—ocular cancer	6.93e-05	0.00058	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—E2F1—ocular cancer	6.84e-05	0.000573	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	6.74e-05	0.000565	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	6.67e-05	0.000558	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	6.65e-05	0.000557	CbGpPWpGaD
Daunorubicin—YWHAG—Membrane Trafficking—AKT1—ocular cancer	6.64e-05	0.000556	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	6.6e-05	0.000553	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—CDK2—ocular cancer	6.59e-05	0.000552	CbGpPWpGaD
Daunorubicin—ABCG2—HIF-1-alpha transcription factor network—AKT1—ocular cancer	6.59e-05	0.000552	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—E2F5—ocular cancer	6.56e-05	0.000549	CbGpPWpGaD
Daunorubicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	6.52e-05	0.000546	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—E2F4—ocular cancer	6.42e-05	0.000538	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—RBL1—ocular cancer	6.3e-05	0.000528	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—RPL39—ocular cancer	6.3e-05	0.000528	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	6.28e-05	0.000526	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—ocular cancer	6.28e-05	0.000526	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—HRAS—ocular cancer	6.27e-05	0.000525	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—CDK4—ocular cancer	6.23e-05	0.000522	CbGpPWpGaD
Daunorubicin—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	6.05e-05	0.000506	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—CDKN1B—ocular cancer	6.03e-05	0.000505	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—MDM2—ocular cancer	5.91e-05	0.000495	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PSPH—ocular cancer	5.91e-05	0.000495	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—CDK2—ocular cancer	5.9e-05	0.000494	CbGpPWpGaD
Daunorubicin—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	5.9e-05	0.000494	CbGpPWpGaD
Daunorubicin—ABCC2—NRF2 pathway—TGFB1—ocular cancer	5.78e-05	0.000484	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—CCND1—ocular cancer	5.75e-05	0.000482	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	5.67e-05	0.000475	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PSPH—ocular cancer	5.58e-05	0.000467	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—CDK4—ocular cancer	5.57e-05	0.000467	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—CDKN1A—ocular cancer	5.57e-05	0.000466	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—MDM2—ocular cancer	5.54e-05	0.000464	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—AKT1—ocular cancer	5.53e-05	0.000463	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	5.48e-05	0.000459	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ocular cancer	5.47e-05	0.000459	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	5.46e-05	0.000457	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—RB1—ocular cancer	5.42e-05	0.000454	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—CDKN1B—ocular cancer	5.39e-05	0.000452	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—GNA11—ocular cancer	5.32e-05	0.000446	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—EP300—ocular cancer	5.3e-05	0.000444	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—TP53—ocular cancer	5.26e-05	0.00044	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	5.2e-05	0.000436	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—CCND1—ocular cancer	5.14e-05	0.000431	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TFDP1—ocular cancer	5.08e-05	0.000425	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—CDKN1A—ocular cancer	4.98e-05	0.000417	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—GNAQ—ocular cancer	4.95e-05	0.000414	CbGpPWpGaD
Daunorubicin—CYP1A1—PPARA activates gene expression—EP300—ocular cancer	4.91e-05	0.000411	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—RB1—ocular cancer	4.85e-05	0.000406	CbGpPWpGaD
Daunorubicin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—ocular cancer	4.8e-05	0.000402	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—EP300—ocular cancer	4.74e-05	0.000397	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	4.62e-05	0.000387	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—MYC—ocular cancer	4.62e-05	0.000387	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	4.48e-05	0.000376	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PSPH—ocular cancer	4.46e-05	0.000373	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—TGFB1—ocular cancer	4.44e-05	0.000372	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	4.3e-05	0.00036	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—MDM2—ocular cancer	4.25e-05	0.000356	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	4.24e-05	0.000355	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—CDKN1B—ocular cancer	4.22e-05	0.000353	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—MDM2—ocular cancer	4.13e-05	0.000346	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—MYC—ocular cancer	4.13e-05	0.000346	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—MYC—ocular cancer	4.08e-05	0.000342	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MAML2—ocular cancer	4.03e-05	0.000338	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—CCND1—ocular cancer	4.02e-05	0.000337	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—GNA11—ocular cancer	3.92e-05	0.000329	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—CDKN1A—ocular cancer	3.89e-05	0.000326	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—CDKN1B—ocular cancer	3.77e-05	0.000316	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—EP300—ocular cancer	3.7e-05	0.00031	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—GNAQ—ocular cancer	3.65e-05	0.000306	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—CCND1—ocular cancer	3.6e-05	0.000301	CbGpPWpGaD
Daunorubicin—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	3.56e-05	0.000298	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PSPH—ocular cancer	3.56e-05	0.000298	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—CDKN1A—ocular cancer	3.48e-05	0.000292	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—TP53—ocular cancer	3.39e-05	0.000284	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—EP300—ocular cancer	3.31e-05	0.000277	CbGpPWpGaD
Daunorubicin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—ocular cancer	3.31e-05	0.000277	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—MYC—ocular cancer	3.23e-05	0.00027	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	3.14e-05	0.000263	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—HRAS—ocular cancer	3.04e-05	0.000255	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HDAC1—ocular cancer	2.95e-05	0.000247	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—GNA11—ocular cancer	2.95e-05	0.000247	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—EP300—ocular cancer	2.94e-05	0.000247	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—MYC—ocular cancer	2.89e-05	0.000242	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	2.87e-05	0.00024	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—GNA11—ocular cancer	2.85e-05	0.000239	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—AKT1—ocular cancer	2.83e-05	0.000237	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PSPH—ocular cancer	2.75e-05	0.00023	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—GNAQ—ocular cancer	2.74e-05	0.00023	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	2.74e-05	0.000229	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—GNAQ—ocular cancer	2.65e-05	0.000222	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	2.65e-05	0.000222	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CDKN2B—ocular cancer	2.64e-05	0.000221	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GNA11—ocular cancer	2.59e-05	0.000217	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GNA11—ocular cancer	2.57e-05	0.000215	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	2.52e-05	0.000211	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GNAQ—ocular cancer	2.41e-05	0.000202	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GNAQ—ocular cancer	2.39e-05	0.0002	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—TP53—ocular cancer	2.37e-05	0.000199	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—HRAS—ocular cancer	2.33e-05	0.000195	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	2.21e-05	0.000185	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	2.2e-05	0.000184	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	2.19e-05	0.000183	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	2.14e-05	0.000179	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GNA11—ocular cancer	1.86e-05	0.000156	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	1.8e-05	0.000151	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—EP300—ocular cancer	1.78e-05	0.000149	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GNA11—ocular cancer	1.76e-05	0.000147	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GNAQ—ocular cancer	1.73e-05	0.000145	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GNAQ—ocular cancer	1.63e-05	0.000137	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	1.52e-05	0.000128	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MDM2—ocular cancer	1.47e-05	0.000123	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GNA11—ocular cancer	1.4e-05	0.000117	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CDKN1B—ocular cancer	1.34e-05	0.000112	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	1.32e-05	0.00011	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—EP300—ocular cancer	1.31e-05	0.00011	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GNAQ—ocular cancer	1.3e-05	0.000109	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CDKN1A—ocular cancer	1.24e-05	0.000104	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—EP300—ocular cancer	1.18e-05	9.85e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GNA11—ocular cancer	1.12e-05	9.38e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—AKT1—ocular cancer	1.07e-05	9e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GNAQ—ocular cancer	1.04e-05	8.72e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MYC—ocular cancer	1.02e-05	8.58e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TGFB1—ocular cancer	1.02e-05	8.56e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—EP300—ocular cancer	9.85e-06	8.25e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—EP300—ocular cancer	9.53e-06	7.98e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—EP300—ocular cancer	8.67e-06	7.26e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GNA11—ocular cancer	8.64e-06	7.24e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—EP300—ocular cancer	8.58e-06	7.18e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	8.4e-06	7.03e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HRAS—ocular cancer	8.05e-06	6.74e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GNAQ—ocular cancer	8.03e-06	6.73e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—AKT1—ocular cancer	7.92e-06	6.64e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—AKT1—ocular cancer	7.11e-06	5.95e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—EP300—ocular cancer	6.21e-06	5.2e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—AKT1—ocular cancer	5.95e-06	4.99e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—EP300—ocular cancer	5.87e-06	4.91e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—AKT1—ocular cancer	5.76e-06	4.82e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—AKT1—ocular cancer	5.24e-06	4.39e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—AKT1—ocular cancer	5.18e-06	4.34e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—EP300—ocular cancer	4.69e-06	3.92e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—AKT1—ocular cancer	3.75e-06	3.14e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—EP300—ocular cancer	3.74e-06	3.13e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—AKT1—ocular cancer	3.55e-06	2.97e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—EP300—ocular cancer	2.89e-06	2.42e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—AKT1—ocular cancer	2.83e-06	2.37e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—AKT1—ocular cancer	2.26e-06	1.89e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—AKT1—ocular cancer	1.74e-06	1.46e-05	CbGpPWpGaD
